Research & Development



  阿嬌皺眉道︰“天底下誰能比您有錢,這樣說很虧心啊。”   他竟然說按照大漢律令,非丞相推薦的官員,陛下無權任命!色天使在线影院超碰   陳銅家大業大,讓長子從軍這實在是說不過去。曰本高清一本道无码av   到了陳銅這個匠戶還沾點商賈身份的人頭上,良家女下嫁,是一件非常丟人的事情,悔婚才是浪子回頭!   桑弘羊驚詫的道︰“微臣寫了奏章,陛下也批閱了,因此,微臣才會允許衛將軍府運行此事,否則,微臣就算有天大的膽子也不敢造次。”52avav我爱aⅴ在线观看 第十三章 不要輸在起跑線上

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo